Literature DB >> 16786384

[Inflammatory spine disease as a cause of back pain].

T Schlossbauer1, A Panteleon, C Becker-Gaab.   

Abstract

PURPOSE: The aim of this review is to evaluate the role of inflammatory spine disease in patients with chronic back pain. The contribution of imaging modalities for the diagnostic evaluation of back pain is discussed.
MATERIAL AND METHODS: A systematic literature search based on the classification of seronegative spondyloarthropathies and rheumatoid arthritis was performed. The results of this search and the experiences in a large collective of rheumatological patients are analyzed.
RESULTS: The prevalence of rheumatoid arthritis (1-2%) is comparable to that of spondyloarthropathies (1.9%). The etiology of these entities is not fully elucidated. Magnetic resonance imaging is increasingly used for early detection and surveillance of therapy with TNF-alpha antagonists. DISCUSSION: Bone marrow edema, which is only detectable with MRI, represents an early sign of inflammation. Therapy with TNF-alpha antagonists is based on clinical and laboratory criteria, and signs of inflammation in MRI. MRI is useful for assessment of the effectiveness of anti-inflammatory therapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16786384     DOI: 10.1007/s00117-006-1387-2

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  38 in total

1.  Interventional MR imaging for injection of sacroiliac joints in patients with sacroiliitis.

Authors:  P L Pereira; I Günaydin; J Trübenbach; F Dammann; C T Remy; I Kötter; F Schick; C W Koenig; C D Claussen
Journal:  AJR Am J Roentgenol       Date:  2000-07       Impact factor: 3.959

Review 2.  Inflammatory disorders of the vertebral column: seronegative spondyloarthropathies, adult-onset rheumatoid arthritis, and juvenile chronic arthritis.

Authors:  D Resnick
Journal:  Clin Imaging       Date:  1989-12       Impact factor: 1.605

3.  Magnetic resonance imaging guided corticosteroid injection of sacroiliac joints in patients with spondylarthropathy. Are multiple injections more beneficial?

Authors:  I Günaydin; P L Pereira; J Fritz; C König; I Kötter
Journal:  Rheumatol Int       Date:  2005-07-12       Impact factor: 2.631

Review 4.  Associations between ankylosing spondylitis, psoriatic arthritis, Reiter's disease, the intestinal arthropathies, and Behcet's syndrome.

Authors:  J M Moll; I Haslock; I F Macrae; V Wright
Journal:  Medicine (Baltimore)       Date:  1974-09       Impact factor: 1.889

Review 5.  Spondyloarthritis: update on pathogenesis and management.

Authors:  John D Reveille; Frank C Arnett
Journal:  Am J Med       Date:  2005-06       Impact factor: 4.965

6.  Distinctive radiological features of small hand joints in rheumatoid arthritis and seronegative spondyloarthritis demonstrated by contrast-enhanced (Gd-DTPA) magnetic resonance imaging.

Authors:  V Jevtic; I Watt; B Rozman; M Kos-Golja; F Demsar; O Jarh
Journal:  Skeletal Radiol       Date:  1995-07       Impact factor: 2.199

7.  Psoriatic spondylitis: a clinical, radiological, and scintiscan survey.

Authors:  D Barraclough; A S Russell; J S Percy
Journal:  J Rheumatol       Date:  1977       Impact factor: 4.666

Review 8.  Magnetic resonance imaging of psoriatic arthritis: insight from traditional and three-dimensional analysis.

Authors:  Saara M S Totterman
Journal:  Curr Rheumatol Rep       Date:  2004-08       Impact factor: 4.592

9.  The relationship of clinical and laboratory measurements to radiological change in ankylosing spondylitis.

Authors:  H G Taylor; T Wardle; E J Beswick; P T Dawes
Journal:  Br J Rheumatol       Date:  1991-10

10.  Natural course of cervical spine lesions in rheumatoid arthritis.

Authors:  T Oda; K Fujiwara; K Yonenobu; B Azuma; T Ochi
Journal:  Spine (Phila Pa 1976)       Date:  1995-05-15       Impact factor: 3.468

View more
  1 in total

1.  Efficacy of an acquainted drug in the treatment of inflammatory low back pain: sulfasalazine under investigation.

Authors:  Jamileh Moghimi; Ali Asghar Rezaei; Raheb Ghorbani; Mohammad Reza Razavi; Daryoush Pahlevan
Journal:  Drug Des Devel Ther       Date:  2016-09-23       Impact factor: 4.162

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.